Related references
Note: Only part of the references are listed.Inflammatory and Cardiac Biomarkers in Relation with Post-Acute COVID-19 and Mortality: What We Know after Successive Pandemic Waves
Catalina Lionte et al.
DIAGNOSTICS (2022)
A Rising Star of the Multimarker Panel: Growth Differentiation Factor-15 Levels Are an Independent Predictor of Mortality in Acute Heart Failure Patients Admitted to an Emergency Clinical Hospital from Eastern Europe
Radu-Stefan Miftode et al.
LIFE-BASEL (2022)
A Real Pandora's Box in Pandemic Times: A Narrative Review on the Acute Cardiac Injury Due to COVID-19
Amalia-Stefana Timpau et al.
LIFE-BASEL (2022)
The Relationship between Cardiovascular Risk Scores and Several Markers of Subclinical Atherosclerosis in an Asymptomatic Population
Ovidiu Mitu et al.
JOURNAL OF CLINICAL MEDICINE (2021)
The Influence of Socioeconomic Status on the Prognosis and Profile of Patients Admitted for Acute Heart Failure during COVID-19 Pandemic: Overestimated Aspects or a Multifaceted Hydra of Cardiovascular Risk Factors?
Radu-Stefan Miftode et al.
HEALTHCARE (2021)
Syndecan-1 in Liver Diseases
Eszter Regos et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Syndecans in Inflammation at a Glance
Sandeep Gopal
FRONTIERS IN IMMUNOLOGY (2020)
Acute heart failure
Mattia Arrigo et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls
Peter Jirak et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Estimated Population Prevalence of Heart Failure with Reduced Ejection Fraction in Spain, According to DAPA-HF Study Criteria
Anna Camps-Vilaro et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Syndecan-1: A Review on Its Role in Heart Failure and Chronic Liver Disease Patients' Assessment
Radu-Stefan Miftode et al.
CARDIOLOGY RESEARCH AND PRACTICE (2019)
Syndecan-1 Predicts Outcome in Patients with ST-Segment Elevation Infarction Independent from Infarct-related Myocardial Injury
Bernhard Wernly et al.
SCIENTIFIC REPORTS (2019)
PLASMA CONCENTRATION OF BIOMARKERS REFLECTING ENDOTHELIAL CELL- AND GLYCOCALYX DAMAGE ARE INCREASED IN PATIENTS WITH SUSPECTED ST-ELEVATION MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK
Martin Frydland et al.
SHOCK (2018)
Established and Emerging Roles of Biomarkers in Heart Failure
Nasrien E. Ibrahim et al.
CIRCULATION RESEARCH (2018)
Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction
Jasper Tromp et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry
Ovidiu Chioncel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Muscle wasting and cachexia in heart failure: mechanisms and therapies
Stephan von Haehling et al.
NATURE REVIEWS CARDIOLOGY (2017)
Evaluation of the endothelial glycocalyx damage in patients with acute coronary syndrome
Carlos Henrique Miranda et al.
ATHEROSCLEROSIS (2016)
Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review
Evelien E. S. van Riet et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
SYNDECAN-1 IS OVEREXPRESSED DURING ATHEROGENESIS
S. Vo et al.
ATHEROSCLEROSIS (2015)
Could Circulatory Syndecan-1 Be a Predictable Biomarker for Acute Kidney Injury in Patients With Acute Decompensated Heart Failure?
Daisuke Sueta et al.
CIRCULATION JOURNAL (2015)
Syndecan-1 in Acute Decompensated Heart Failure - Association With Renal Function and Mortality
Fernanda Macedo de Oliveira Neves et al.
CIRCULATION JOURNAL (2015)
Syndecan-1 and Its Expanding List of Contacts
Mary Ann Stepp et al.
ADVANCES IN WOUND CARE (2015)
Fibrosis Marker Syndecan-1 and Outcome in Patients With Heart Failure With Reduced and Preserved Ejection Fraction
Jasper Tromp et al.
CIRCULATION-HEART FAILURE (2014)
Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody
Yosdel Soto et al.
MABS (2014)
HDL and endothelial protection
A. Tran-Dinh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature
Jill Vanmassenhove et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines
Sisse R. Ostrowski et al.
CRITICAL CARE (2013)
Endothelial Glycocalyx: Permeability Barrier and Mechanosensor
F. E. Curry et al.
ANNALS OF BIOMEDICAL ENGINEERING (2012)
Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: A complex relationship
Sameer Ather et al.
AMERICAN HEART JOURNAL (2011)
Syndecan-1 A Critical Mediator in Cardiac Fibrosis
Nikolaos G. Frangogiannis
HYPERTENSION (2010)
Syndecan-1 Amplifies Angiotensin II-Induced Cardiac Fibrosis
Mark W. M. Schellings et al.
HYPERTENSION (2010)
Decoupled syndecan 1 mRNA and protein expression is differentially regulated by angiotensin II in macrophages
Wenli Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
R Bellomo et al.
CRITICAL CARE (2004)
Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface
AA Constantinescu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Share Paper
